Blog

Pearl IRB updated fee schedule in effect March 31, 2014

Please note that effective March 31, 2014, Pearl IRB has changed it’s fee schedule. To see pricing for your upcoming study, see our 2014 Fee Schedule.  Please contact us at info@pearlirb.com for a price quote for Central IRB services, detailed pricing of your research...

read more

New LinkedIn page for Pearl Pathways

Pearl Pathways is excited to publish our new LinkedIn Company Page. Please click this link to follow us. The Pearl Pathways LinkedIn page will enclose information about the company and the services we provide. We will also post the most important industry and company...

read more

FDA adopt guidelines from ICH

Alexander Gaffney from raps.org has just released an article on regulators releasing the latest guideline on electronically transmitting individual case safety reports (ICSR) from the International Conference on Harmonisation’s (ICH). ICH is a pharmaceutical...

read more

Drug approval falls in 2013

Uk.reuters.com just released an article about the lackluster number of approved drugs by FDA in 2013. In 2013 only 27 were approved vs. 39 in 2012, which was the most since 1997. FDA attributed the large decrease to fewer applications in 2013 which was down from 41 to...

read more